Actuate Therapeutics Inc
ACTU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $18,676 | $21,708 | $16,387 |
| G&A Expenses | $6,484 | $3,265 | $3,820 |
| SG&A Expenses | $6,484 | $3,265 | $3,820 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $25,161 | $24,974 | $20,207 |
| Operating Income | -$25,161 | -$24,974 | -$20,207 |
| % Margin | – | – | – |
| Other Income/Exp. Net | -$2,124 | $229 | $47 |
| Pre-Tax Income | -$27,285 | -$24,745 | -$20,159 |
| Tax Expense | $1 | $0 | $0 |
| Net Income | -$27,285 | -$24,745 | -$20,159 |
| % Margin | – | – | – |
| EPS | -3.26 | -1.65 | -1.34 |
| % Growth | -97.6% | -23.1% | – |
| EPS Diluted | -3.26 | -1.65 | -1.34 |
| Weighted Avg Shares Out | 19,515 | 15,034 | 15,034 |
| Weighted Avg Shares Out Dil | 19,515 | 15,034 | 15,034 |
| Supplemental Information | – | – | – |
| Interest Income | $222 | $353 | $27 |
| Interest Expense | -$19 | $44 | $16 |
| Depreciation & Amortization | $2,143 | $273 | $64 |
| EBITDA | -$25,161 | -$24,428 | -$20,080 |
| % Margin | – | – | – |